Thu, Oct 30, 2014, 11:25 AM EDT - U.S. Markets close in 4 hrs 35 mins

Recent

% | $
Quotes you view appear here for quick access.

Colgate-Palmolive Co. Message Board

joe_techi 6 posts  |  Last Activity: Oct 15, 2014 8:41 PM Member since: Jul 18, 2000
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • joe_techi joe_techi Oct 15, 2014 8:41 PM Flag

    ebola...imo

  • I put 25k out there at 0.32 AON and....executed. I would need to look at level 2 during the spike to understand better how I feel about that....other than I got 32 instead of the guaranteed 27. I think I feel good about that, lol

  • Reply to

    I doubt it's informed buying

    by participant42 Oct 15, 2014 2:08 PM
    joe_techi joe_techi Oct 15, 2014 3:24 PM Flag

    Maybe it is a suitor that wants to buy Corgenix and is willing to pay more than 27 cents. So they buy all they can at prices below what they are willing to offer which is higher than the current 27 cents? Say they are willing to pay 32 cents, it would benefit them to gobble up all the shares they could below 32 cents.....maybe?

  • joe_techi by joe_techi Oct 10, 2014 9:30 AM Flag

    Use the Freedom Of Information Act (FOIA) to get data on the NIH ebola contract including cost, funding growth, performance, contract modifications, etc. This process takes a while. It may show the contract is growing....or it may show them purposely not performing with government funds for the sake of lining their pockets.

    "Corgenix currently serves as the principal investigator for the new NIH-funded three-year contract to complete the development of recombinant diagnostic tests for Ebola.

    The most recent grant was awarded to Corgenix and members of the Viral Hemorrhagic Fever Consortium (VHFC), a collaboration of academic and industry members headed by Tulane University. The NIH phase II, R44 grant was awarded to Corgenix and VHFC to develop rapid diagnostic tests (RDT) for Ebola, enabling rapid response to public health and bioterrorism threats posed by the deadly virus. Corgenix and the VHFC have previously developed and CE marked the ReLASV® rapid test for the Lassa fever virus."

  • Ebola is everywhere....who would have ever thought....and..."Corgenix Medical Corporation (OTC BB: CONX.OB), a worldwide developer and marketer of diagnostic test kits, has been awarded a three-year, $2.9 million National Institutes of Health (NIH) grant to advance the development of an Ebola rapid diagnostic test kit.

    Good deal...Finally a chance to make some $$$$s....Figure the visionary expertise....or luck, regardless.....We have positioned ourselves for a once in a lifetime opportunity....We have funding....This stock should skyrocket....Oh WHAT? We sold for 27 CENTS?!!! WT....F?

  • 60 cents per share and outperform? They got half of their prediction right.....and less than 1/2 of the other portion

CL
66.11+0.26(+0.39%)11:25 AMEDT

Trending Tickers

i
Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.